Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Lancet Gastroenterol Hepatol. 2018 Dec;3(12):874–883. doi: 10.1016/S2468-1253(18)30237-1

Table 4.

Genes with evidence for gastric cancer causality

Gene Evidence for
causality
Familial Cancer Syndrome Evidence Evidence from next generation sequencing
studies
Cancer syndrome Gastric cancer
related
syndrome?
Mutated? Recurrently
mutated?
Gastric cancer
related pathway?
Tier 1
CDH1 Strong HDGC Yes NA NA CDH1
PALB2 Strong Breast/ Pancreas cancer No Yes25,28,36,42 Yes HRDR
Tier 2
CTNNA1 Moderate HDGC Yes Yes 36 Yes CDH1
MSH2 Moderate LS Yes Yes 31,42 Yes No
TP53 Moderate LFS Yes Yes 31 No No
STK11 Moderate PJS Yes Yes 36 Yes No
ATM Moderate Breast cancer No Yes 25,31,36 Yes HRDR
BRCA1 Moderate HBOC Yes Yes 25,28 Yes HRDR
BRCA2 Moderate HBOC Yes Yes 25,31,36 Yes HRDR
BRIP1 Moderate Breast cancer No Yes 25,31 Yes HRDR
ATR Moderate None No Yes 31,42 HRDR
Tier 3
APC Moderate/low FAPS Yes No No No
SMAD4 Moderate/low JPS Yes No No No
BMPR1A Moderate/low JPS Yes No No No
ENG Moderate/low JPS Yes No No No
MSR1 Moderate/low Oeasophageal No Yes 42 Yes No
SDHB Moderate/low Paraganglioma-
Pheochromocytoma
No Yes 36 No SDHA/B
SDHA Moderate/low Paraganglioma-
Pheochromocytoma
No Yes 25 No SDHA/B
RAD51C Moderate/low Breast cancer No Yes 28 No HRDR
NBN Moderate/low Ovarian cancer No Yes 42 No HRDR
RECQL5 Moderate/low Breast cancer No Yes 42 No HRDR
FANCC Moderate/low Breast cancer No Yes 31 No HRDR